-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report) shares were down 8% on Tuesday . The company traded as low as $7.26 and last traded at $7.49. Approximately 1,334,198 shares changed hands during mid-day trading, a decline of 60% from the average daily volume of 3,376,665 shares. The stock had previously closed at $8.14.
Mind Medicine (MindMed) Stock Down 8.0 %
The business has a 50 day moving average of $6.68 and a two-hundred day moving average of $7.08.
About Mind Medicine (MindMed)
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Read More
- Five stocks we like better than Mind Medicine (MindMed)
- How to Find Undervalued Stocks
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- What are earnings reports?
- Netflix Is On Track To Hit $1,000 By Christmas
- Insider Selling Explained: Can it Inform Your Investing Choices?
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
